Back

Intensive prevention program after myocardial infarction: how can LDL cholesterol be reduced and how long are intensive prevention efforts needed?

26 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Refining secondary prevention Secondary Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Stephan Michel

Hospital Links der Weser, Bremen (Germany)

6 More presentations in this session

Presentation thumbnail
Which role plays the school degree in effectiveness of prevention after myocardial infarction?
Doctor T. Backhaus (Bremen, DE)
Abstract Slides
Presentation thumbnail
Association between early invasive management, secondary preventive medical therapy and long-term outcomes after acute coronary syndromes
Doctor S. Galatius (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Clinical impact of cardiac rehabilitation according to the atherothrombotic risk stratification after acute myocardial infarction. The FAST-MI registries.
Doctor E. Puymirat (Paris, FR)
Abstract Slides
Presentation thumbnail
The effect of weight loss and exercise on heart rate variability in patients with coronary artery disease. The randomised CUT-IT trial
Doctor L. Pedersen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Impact of smoking on bleeding after percutaneous coronary intervention 1-year results
Doctor L. Yang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Refining secondary prevention

The Event

Event poster

ESC Congress 2018

26 August 2018 10:05 CET
You may be interested in
thumbnail
Congress Presentation
Long-term monitoring and follow up of cLDL levels and treatment adherence in low-risk ischemic heart disease patients discharged from the cardiac rehabilitation unit to primary care
30 August 2025
thumbnail
Webinar
Acute LDL-C reduction during and immediately after ACS: is it prime time?
7 February 2022
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources